Moxetumomab Pasudotox-Tdfk Injection
15 interactions 17 cited referencesMoxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia (cancer of a certain type of white blood cell) that has returned or has not responded after at least two other cancer treatments. Moxetumomab pasudotox-tdfk injection is in a class of medications called monoclonal antibodies. It works by helping… Read the full Moxetumomab Pasudotox-Tdfk Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Moxetumomab Pasudotox-Tdfk Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Moxetumomab Pasudotox-Tdfk Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Moxetumomab Pasudotox-Tdfk Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Moxetumomab Pasudotox-Tdfk Injection Ebola Zaire Vaccine, Live An increased risk of infection by the live vaccine Details Moxetumomab Pasudotox-Tdfk Injection Influenza Virus Vaccine, Live An increased risk of infection by the live vaccine Details Moxetumomab Pasudotox-Tdfk Injection Rotavirus Vaccine, Live An increased risk of infection by the live vaccine DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist